QualityCounts.com  
Home iHerb Int Antiaging Sys LEF at Amazon LEF at LEF Amazon.com Contact
 Newsletter Archive
 Newsletter via RSS Feed
 Research on Supplements
 Health Conditions
 Anti-aging Recommendations
 Insulin and Aging
 QualityCounts.com in Time
 Longevity Affiliates:
 iHerb
 Int. Anti-aging Systems
 Puritan's Pride
 Vitamin Shoppe
 Vital Choice Seafood
 
Please support this website by purchasing via the links on the website.

Home > Health Conditions > Diabetes > Januvia (sitagliptin)

Januvia (sitagliptin phosphate)

Related Topics:

Where to purchase:

News & Research:

  • Januvia (sitagliptin phosphate) - rxlist.com - "By increasing and prolonging active incretin levels, JANUVIA increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner"
  • Metformin vs. Sulfonylureas for Diabetes - WebMD, 12/4/09 - "Researchers reported that diabetes patients who used sulfonylureas had a higher risk of death from all causes and a higher risk of heart failure than diabetes patients who used the most widely prescribed diabetes drug, metformin ... Compared with metformin, also known as Glucophage, single-drug treatment with first- and second-generation sulfonylureas was associated with up to a 61% increased risk for death. Users of second-generation sulfonylureas had up to a 30% higher risk for congestive heart failure ... Patients treated with Actos or Avandia did not appear to have a greater risk for heart attacks than those treated with metformin"
  • Two-Year Sitagliptin With or Without Metformin Shows Strong and Durable Effects in Type 2 Diabetes - Doctor's Guide, 9/10/08
  • FDA Approves New Treatment for Diabetes - Doctor's Guide, 10/17/07 - "Januvia prolongs the activity of proteins that increase the release of insulin after blood sugar rises, such as after a meal. Januvia does this by blocking an enzyme (dipeptidyl peptidase IV or DPP-IV) which breaks down these proteins, leading to better blood sugar control"
  • FDA Approves Once-Daily Januvia(TM) (Sitagliptin Phosphate), the First and Only DPP-4 Inhibitor Available in the United States for Type 2 Diabetes - Doctor's Guide, 10/18/06 - "By adding Januvia to the insulin sensitizers metformin or pioglitazone (a TZD), the three key defects of type 2 diabetes can be addressed: insulin resistance, beta-cell dysfunction (decreased insulin release), and alpha-cell dysfunction (unsuppressed hepatic glucose production)"
  • FDA OKs New Type 2 Diabetes Drug - WebMD, 10/17/06
  • New oral diabetes drug gets FDA approval - MSNBC, 10/17/06 - "The Food and Drug Administration said it approved Januvia, which enhances the body’s own ability to lower blood sugar levels, after clinical trials showing the new pill works just as well as older diabetes drugs, but with fewer side effects like weight gain"

Abstracts:

Related Sites:

70526

  QualityCounts.com Anti-aging Newsletter
Newsletter Sign-up
Add to Netvibes

Netvibes basic (free)

Join QualityCounts.com on Facebook